NCT07040579View on ClinicalTrials.gov

Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

September 30, 2032

Study Completion Date

December 31, 2032

Conditions
Congenital Heart DefectsVSD
Interventions
DEVICE

transcatheter closure of outlet VSDs with bioabsorbable occluders

Transcatheter closure of outlet ventricular septal defects using a bioabsorbable occluder (Shape Memory Alloy Ltd, Shanghai, China). Implantation is performed via femoral/transthoracic approach under echocardiographic guidance following standard interventional protocols.

Trial Locations (1)

530021

The First Affiliated Hospital of Guangxi Medical University, Nanning

All Listed Sponsors
lead

First Affiliated Hospital of Guangxi Medical University

OTHER